Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cario

Showing results (481-490 of 548) with videos related to

Pageof 55
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2025
Reducing Daunorubicin in Induction Therapy in Children With B-Lineage ALL With Favorable Prognosis: Results of Phase III Trial AIEOP-BFM ALL 2009Hanna Gottschalk, Anja Möricke, Valentino Conter, et al.
European Journal of Cancer (Oxford, England : 1990)|October 21, 2019
Outcome of adolescent patients with acute lymphoblastic leukaemia aged 10-14 years as compared with those aged 15-17 years: Long-term results of 1094 patients of the AIEOP-BFM ALL 2000 studyAnna Maria Testi, Andishe Attarbaschi, Maria Grazia Valsecchi, et al.
Molecular Cancer|July 5, 2024
Distinct pattern of genomic breakpoints in CML and BCR::ABL1-positive ALL: analysis of 971 patientsLenka Hovorkova, Lucie Winkowska, Justina Skorepova, et al.
AJNR. American Journal of Neuroradiology|September 22, 2022
MR Imaging and Clinical Characteristics of Diffuse Glioneuronal Tumor with Oligodendroglioma-like Features and Nuclear ClustersM Benesch, T Perwein, G Apfaltrer, et al.
Hemasphere|June 12, 2023
Definition and Prognostic Value of Ph-like and IKZF1plus Status in Children With Down Syndrome and B-cell Precursor Acute Lymphoblastic LeukemiaChiara Palmi, Silvia Bresolin, Stefanie Junk, et al.
Blood|December 8, 2009
Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study GroupLibi Hertzberg, Elena Vendramini, Ithamar Ganmore, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 13, 2023
Chemotherapy-related hyperbilirubinemia in pediatric acute lymphoblastic leukemia: a genome-wide association study from the AIEOP-BFM ALL study groupStefanie V Junk, Elke Schaeffeler, Martin Zimmermann, et al.
British Journal of Haematology|July 24, 2012
Treatment outcome of CRLF2-rearranged childhood acute lymphoblastic leukaemia: a comparative analysis of the AIEOP-BFM and UK NCRI-CCLG study groupsAndishe Attarbaschi, Maria Morak, Gunnar Cario, et al.
Blood|March 25, 2025
NGS-based IG/TR rearrangement profiling in acute lymphoblastic leukemia: age dependence of immunogenetic maturationMichaela Kotrova, Constantin Proske, Nikos Darzentas, et al.
Ebiomedicine|May 29, 2024
An artificial intelligence-assisted clinical framework to facilitate diagnostics and translational discovery in hematologic neoplasiaMing Tang, Željko Antić, Pedram Fardzadeh, et al.
Pageof 55

Showing results (481-490 of 548) with videos related to

Sort By:
Pageof 55
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2025
Reducing Daunorubicin in Induction Therapy in Children With B-Lineage ALL With Favorable Prognosis: Results of Phase III Trial AIEOP-BFM ALL 2009Hanna Gottschalk, Anja Möricke, Valentino Conter, et al.
European Journal of Cancer (Oxford, England : 1990)|October 21, 2019
Outcome of adolescent patients with acute lymphoblastic leukaemia aged 10-14 years as compared with those aged 15-17 years: Long-term results of 1094 patients of the AIEOP-BFM ALL 2000 studyAnna Maria Testi, Andishe Attarbaschi, Maria Grazia Valsecchi, et al.
Molecular Cancer|July 5, 2024
Distinct pattern of genomic breakpoints in CML and BCR::ABL1-positive ALL: analysis of 971 patientsLenka Hovorkova, Lucie Winkowska, Justina Skorepova, et al.
AJNR. American Journal of Neuroradiology|September 22, 2022
MR Imaging and Clinical Characteristics of Diffuse Glioneuronal Tumor with Oligodendroglioma-like Features and Nuclear ClustersM Benesch, T Perwein, G Apfaltrer, et al.
Hemasphere|June 12, 2023
Definition and Prognostic Value of Ph-like and IKZF1plus Status in Children With Down Syndrome and B-cell Precursor Acute Lymphoblastic LeukemiaChiara Palmi, Silvia Bresolin, Stefanie Junk, et al.
Blood|December 8, 2009
Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study GroupLibi Hertzberg, Elena Vendramini, Ithamar Ganmore, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 13, 2023
Chemotherapy-related hyperbilirubinemia in pediatric acute lymphoblastic leukemia: a genome-wide association study from the AIEOP-BFM ALL study groupStefanie V Junk, Elke Schaeffeler, Martin Zimmermann, et al.
British Journal of Haematology|July 24, 2012
Treatment outcome of CRLF2-rearranged childhood acute lymphoblastic leukaemia: a comparative analysis of the AIEOP-BFM and UK NCRI-CCLG study groupsAndishe Attarbaschi, Maria Morak, Gunnar Cario, et al.
Blood|March 25, 2025
NGS-based IG/TR rearrangement profiling in acute lymphoblastic leukemia: age dependence of immunogenetic maturationMichaela Kotrova, Constantin Proske, Nikos Darzentas, et al.
Ebiomedicine|May 29, 2024
An artificial intelligence-assisted clinical framework to facilitate diagnostics and translational discovery in hematologic neoplasiaMing Tang, Željko Antić, Pedram Fardzadeh, et al.
Pageof 55